REFERENCES
- Paton L. Papilloedema and optic neuritis. Trans Sect Ophthalmol Am Med Assoc 1935; 30: 98–119
- Petrohelos M, Henderson J. The ocular findings of intracranial tumours. Trans Am Acad Ophthalmol 1950; 55: 89–98
- Huber A. Eye signs and symptoms in brain tumours, 3rd ed. Mosby, St. Louis 1976; 109–13
- Walsh F, Hoyt W. Clinical neuro-ophthalmology, 3rd ed. Williams & Wilkins, Baltimore 1969; Vol 1: 586–8
- Miller N, Newman N. Walsh & Hoyt's clinical neuro-ophthalmology, 5th ed. Williams & Wilkins, Baltimore, MD 1998; Vol 1: 487–538
- Hartmann E, Guillaumat L. Aspect du fond d'oeil dans les tumeurs intracraiennes Etudu statistique. Ann oculist 1938; 175: 717–37
- Lofgren J, Zwetnow N N. Cranial and spinal components of the cerebrospinal fluid pressure—volume curve. Acta Neurol Scand 1973; 49: 575–85
- Shakhnovich A R, Shakhnovich V A, Galushkina A A. Noninvasive assessment of the elastance and reserve capacity of the craniovertebral contents via FV measurements in the straight sinus by TCD during body tilting test. J Neuroimaging 1999; 9: 141–9
- Corbett J J, Savino P J, Thompson H S, Kansu T, Schatz N J, Orr L S, Hopson D. Visual loss in pseudotumour cerebri. Follow-up of 57 patients from five to 41years and a profile of 14 patients with permanent severe visual loss. Arch Neurol 1982; 39: 461–74
- Wall M, Hart W M, Jr, Burde R M. Visual field defects in idiopathic intracranial hypertension (pseudotumour cerebri). Am J Ophthalmol 1983; 96: 654–69
- Chou S, Digre K. Neuro-ophthalmic complications of raised intracranial pressure, hydrocephaslus, and shunt malformation. Neurosurg Clin N Am 1999; 10: 587–608
- Schirmer C M, Hedges T R, 3rd. Mechanims of visual loss in papilloedema. Neurosurg Focus 2007; 23: E5
- Orcutt J C, Page N G, Sanders M D. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 1984; 91: 1303–12